The overall survival rates (P = 0.001) and disease-free survival rates (P = 0.004) revealed that high expression of RBM17 was positively correlated with shorter survival time and worse prognosis in HCC (Fig 2C and 2D). Here, RBM17 is linked to hepatocellular carcinoma.